Impact of prophylactic gastrostomy or reactive NG tube upon patient-reported long term swallow function following chemoradiotherapy for oropharyngeal carcinoma: A matched pair analysis

Long term dysphagia remains a major treatment-related morbidity of organ preserving approaches to the treatment of head and neck cancers [1–5], with the use of concurrent chemotherapy identified as a significant clinical factor associated with risk of long term dysphagia [6,7]. Dysphagia has a major detrimental effect upon health-related quality-of-life, with multiple studies reporting an association between health-related quality of life and dysphagia [4,8,9]. In a patient questionnaire study, swallowing was rated by a majority of patients as a priority concern 12months following completion of (chemo)radiotherapy [8].

from #ORL via xlomafota13 on Inoreader http://ift.tt/28VoyD1
via IFTTT